The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
114673818 11467381 8 F 20140903 20160708 20150908 20160718 EXP CA-ROCHE-1631126 ROCHE 72.19 YR M Y 112.00000 KG 20160718 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
114673818 11467381 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous 375 MG, BIW (EVERY 2 WEEKS) U S0060A,S0066B,S0001E 103976 375 MG QOW
114673818 11467381 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0060A,S0066B,S0001E 103976
114673818 11467381 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0060A,S0066B,S0001E 103976 375 MG QOW
114673818 11467381 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0060A,S0066B,S0001E 103976
114673818 11467381 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0060A,S0066B,S0001E 103976
114673818 11467381 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0060A,S0066B,S0001E 103976
114673818 11467381 7 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0060A,S0066B,S0001E 103976
114673818 11467381 8 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0060A,S0066B,S0001E 103976
114673818 11467381 9 C SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Unknown U 0
114673818 11467381 10 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Unknown U 0
114673818 11467381 11 C VENTOLIN ALBUTEROL SULFATE 1 Unknown U 0
114673818 11467381 12 C AVAMYS FLUTICASONE FUROATE 1 Unknown U 0
114673818 11467381 13 C INSULIN INSULIN NOS 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
114673818 11467381 1 Asthma
114673818 11467381 9 Product used for unknown indication
114673818 11467381 10 Product used for unknown indication
114673818 11467381 11 Product used for unknown indication
114673818 11467381 12 Product used for unknown indication
114673818 11467381 13 Type 2 diabetes mellitus

Outcome of event

Event ID CASEID OUTC COD
114673818 11467381 OT
114673818 11467381 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
114673818 11467381 Blood pressure systolic increased
114673818 11467381 Drug ineffective
114673818 11467381 Fall
114673818 11467381 Heart rate increased
114673818 11467381 Hypoglycaemia
114673818 11467381 Lower respiratory tract infection
114673818 11467381 Pneumonia
114673818 11467381 Poor quality sleep
114673818 11467381 Pruritus
114673818 11467381 Pruritus generalised
114673818 11467381 Pulmonary congestion
114673818 11467381 Respiratory disorder
114673818 11467381 Respiratory rate increased
114673818 11467381 Seizure
114673818 11467381 Suffocation feeling
114673818 11467381 Weight decreased
114673818 11467381 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
114673818 11467381 1 20140903 0
114673818 11467381 2 20141126 0
114673818 11467381 3 20150305 0
114673818 11467381 4 20150902 0
114673818 11467381 5 20141015 0
114673818 11467381 6 20160205 0
114673818 11467381 7 20160511 0
114673818 11467381 8 20160608 0